| COVID-19 and healthcare impacts | Lifetime | 667 | GB 114 | 93.53 |
| Social Media in Health Education | Lifetime | 123 | GB 12 | 95.58 |
| Inflammatory Myopathies and Dermatomyositis | Lifetime | 299 | GB 23 | 95.83 |
| Skin Diseases and Diabetes | Lifetime | 230 | GB 16 | 93.44 |
| Artificial Intelligence in Healthcare and Education | Lifetime | 534 | GB 47 | 90.54 |
| Spondyloarthritis Studies and Treatments | Lifetime | 894 | GB 90 | 92.36 |
| Musculoskeletal Disorders and Rehabilitation | Lifetime | 626 | GB 89 | 86.17 |
| Muscle and Compartmental Disorders | Lifetime | 891 | GB 65 | 86.54 |
| Parkinson's Disease and Spinal Disorders | Lifetime | 779 | GB 52 | 73.61 |
| Academic Publishing and Open Access | Lifetime | 667 | GB 63 | 55.98 |
| Inflammatory Myopathies and Dermatomyositis | 2021-2025 | 7 | GB 2 | 99.44 |
| Skin Diseases and Diabetes | 2021-2025 | 2 | GB 1 | 98.82 |
| Social Media in Health Education | 2021-2025 | 7 | GB 1 | 97.86 |
| Musculoskeletal Disorders and Rehabilitation | 2021-2025 | 6 | GB 1 | 96.46 |
| Autoimmune and Inflammatory Disorders Research | 2021-2025 | 89 | GB 13 | 97.58 |
| Immunodeficiency and Autoimmune Disorders | 2021-2025 | 178 | GB 11 | 95.44 |
| Systemic Sclerosis and Related Diseases | 2021-2025 | 147 | GB 10 | 94.95 |
| Rheumatoid Arthritis Research and Therapies | 2021-2025 | 237 | GB 30 | 96.32 |
| Eosinophilic Disorders and Syndromes | 2021-2025 | 115 | GB 8 | 94.86 |
| Peripheral Neuropathies and Disorders | 2021-2025 | 235 | GB 12 | 93.51 |
| Artificial Intelligence in Healthcare and Education | 2021-2025 | 512 | GB 40 | 89.59 |
| Health Literacy and Information Accessibility | 2021-2025 | 190 | GB 8 | 88.07 |
| Systemic Lupus Erythematosus Research | 2021-2025 | 928 | GB 68 | 89.26 |
| Spondyloarthritis Studies and Treatments | 2021-2025 | 436 | GB 35 | 87.74 |
| Muscle and Compartmental Disorders | 2021-2025 | 145 | GB 17 | 79.73 |
| Muscle Physiology and Disorders | 2021-2025 | 819 | GB 70 | 82.73 |
| Celiac Disease Research and Management | 2021-2025 | 374 | GB 20 | 79.64 |
| Dermatological and COVID-19 studies | 2021-2025 | 283 | GB 7 | 70.12 |
| Dermatological and Skeletal Disorders | 2021-2025 | 224 | GB 8 | 70.68 |
| Parkinson's Disease and Spinal Disorders | 2021-2025 | 174 | GB 9 | 69.61 |
| Heparin-Induced Thrombocytopenia and Thrombosis | 2021-2025 | 510 | GB 49 | 67.34 |
| Empathy and Medical Education | 2021-2025 | 592 | GB 67 | 64.09 |
| Academic integrity and plagiarism | 2021-2025 | 172 | GB 15 | 60.43 |
| Sex and Gender in Healthcare | 2021-2025 | 776 | GB 70 | 38.90 |
| Intramuscular injections and effects | 2021-2025 | 361 | GB 18 | 35.71 |
